Recon: FDA approves 2mg dose of Novo’s diabetes drug Ozempic; Vaccine industry facing slowing demand, possible glut of COVID-19 vaccines
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy